Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian Biobank

26 Apr 2024

Abstract excerpt

Background: Schizophrenia (SCZ) patients exhibit 30% higher prevalence of metabolic syndrome (MetS) compared to the general population with its suboptimal management contributing to increased mortality. Large-scale studies providing real-world evidence of the underlying causes remain limited. Methods: To address this gap, we used real-world health data from the Estonian Biobank, spanning a median follow-up of ten...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet and metabolism studies
Share to Genetic Associations and Epidemiology
Share to Schizophrenia research and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38707868
DOI: 10.1016/j.lanepe.2024.100914

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian BiobankPMID 38707868Read ↗

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

Genome-wide associations with metabolic syndrome among UK Biobank participants reporting use of second-generation antipsychotics.Semantic proximity Read ↗

Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second-Generation Antipsychotics (SGA)-Induced Metabolic Syndrome (MetS).Semantic proximity Read ↗

Quantifying the Relative Importance of Genetics and Environment on the Comorbidity between Mental- and Cardiometabolic Disorders: A Comprehensive Analysis of National Register Data from 17 million ScandinaviansSemantic proximity Read ↗

Quantifying the relative importance of genetics and environment on the comorbidity between mental and cardiometabolic disorders using 17 million ScandinaviansSemantic proximity Read ↗

Shared genetic components between metabolic syndrome and schizophrenia: Genetic correlation using multipopulation data sets.Semantic proximity Read ↗

Prevalence and factors associated of metabolic syndrome in first- treatment drug-naïve schizophrenia patients: a large-scale cross- sectional studySemantic proximity Read ↗

Schizophrenia and co-morbidity risk: Evidence from a data driven phenomewide association study.Semantic proximity Read ↗

Identifying genetic contributions of 6q21 loci and PPAR pathway to antipsychotic-induced metabolic syndrome: a Sex-Stratified Multi-Omics study.Semantic proximity Read ↗

Cross-population validation of European GWAS loci for metabolic syndrome in Chinese schizophrenia.Semantic proximity Read ↗

Genomic and transcriptomic insights into antipsychotic-induced changes in total cholesterol and body mass index in a multi-ancestry cohort of the US veteransSemantic proximity Read ↗

Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.